by CheckRare Staff | Feb 16, 2024
Wei Ying Jen, MD, of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, discusses Philadelphia chromosome-positive acute lymphoblastic leukemia and treatment options. Philadelphia chromosome (Ph)-positive acute lymphoblastic...
by Madaline Spencer | Feb 15, 2024
Roger A. Levy, MD, Senior Global Medical Director, GSK Specialty Medicine, discusses Lupus nephritis, a rare kidney disorder. Lupus nephritis is a rare autoimmune, kidney disorder that is a complication of systemic lupus erythematous, commonly known as...
by CheckRare Staff | Feb 13, 2024
Jörg Schüttrumpf, MD, Chief Scientific Innovation Officer at Grifols, discusses the Phase 1/2 study evaluating a breakthrough treatment option for alpha1-antitrypsin deficiency. Alpha-1 antitrypsin deficiency (AATD) is an inherited disease caused by...
by Madaline Spencer | Feb 12, 2024
Orlando Agrippa, Founder and CEO of Sanius Health, and Oliver Shastri, team lead for sickle cell disease at Pfizer, discuss how social media can foster community for sickle cell disease patients. Sickle cell disease is a disorder in which red blood cells...
by CheckRare Staff | Feb 10, 2024
Jatin Shah, MD, PhD, of Sumitomo Pharma, discusses two treatments in Phase 1 trials for myelofibrosis and acute myeloid leukemia. Jatin Shah, MD, PhD, of Sumitomo Pharma, discusses two treatments in Phase 1 trials for myelofibrosis and acute myeloid...
